XML 126 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation Plans
6 Months Ended
Jun. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Plans

8. Stock-Based Compensation Plans

Stock-based compensation expense for the three and six months ended June 30, 2013 and 2012 was as follows:

 

     Three Months Ended June 30,      Six Months Ended June 30,  
     2013      2012      2013      2012  
     (In thousands)  

Employee:

           

Restricted stock and performance shares

   $ 1,848       $ 1,806       $ 3,497       $ 3,474   

Stock options

     226         161         423         306   
  

 

 

    

 

 

    

 

 

    

 

 

 
     2,074         1,967         3,920         3,780   
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-employee directors:

           

Restricted stock

     106         99         258         248   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation

   $ 2,180       $ 2,066       $ 4,178       $ 4,028   
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company records stock-based compensation for employees in employee compensation and benefits and for non-employee directors in general and administrative expenses in the Consolidated Statements of Operations.

 

During the six months ended June 30, 2013, the Company granted to employees a total of 214,622 shares of restricted stock or restricted stock units, performance-based shares with an expected pay-out at target of 42,908 shares of common stock and 51,597 options to purchase shares of common stock. The fair value of the restricted stock and performance-based share awards was based on a weighted-average grant date fair value per share of $37.80 and $35.98, respectively. Based on the Black-Scholes option pricing model, the weighted-average fair value for each option granted was $19.62 per share. As of June 30, 2013, the total unrecognized compensation cost related to non-vested awards was $16.0 million. That cost is expected to be recognized over a weighted-average period of 2.4 years.